drugset / Trial / NCT02790099

Comparison of Surgical Rectus Sheath Block and Intrathecal Morphine

NCT02790099 ↗

Phase 4 Completed 144 enrolled Queen Mary Hospital, Hong Kong
RandomizedParallel-groupTriple-blindTreatment

Summary

Pain is the main obstacle in delaying postoperative recovery and leads to prolonged hospital stay. Administration of intrathecal morphine during spinal anaesthesia can provide effective pain control. However, it is associated with significant side effects including nausea, vomiting and itchiness. Also, it is not suitable in all patients, for example, those with morphine allergy, or severe respiratory disease. Surgical rectus sheath block involves injection of local anaesthetic agents into the rectus sheath space before closure of the wound. It has been shown to provide adequate pain control with less systemic side effects. The aim of the study is to evaluate the effectiveness of surgical rectus sheath block and intrathecal morphine in post-Caesarean section pain control.

Timeline

Start
2014-09
Primary completion
2016-01
Completion
2016-06

Outcome

Mixed primary results

paper MAIN OUTCOME MEASURES: Morphine consumption and mean resting pain intensity numerical rating scale at 12 and 24 hours were the primary outcome variables. PMID 22686512 ↗

paper Morphine requirements were significantly less in the bupivacaine group, 19.0 mg/woman, compared with 24.0 mg/woman in the placebo group PMID 22686512 ↗

paper Over the whole first postoperative 24 hours, there were no differences in either morphine requirement or pain intensity between groups. PMID 22686512 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 2.5 mg/ml Other
Subject Bupivacaine Other / unclassified 40 ml Other
Comparator Morphine Other / unclassified 0.1 mg Intrathecal

Indications

No indication recorded.